PTJ
CVS icon

Paul Tudor Jones’s CVS Health CVS Stock Holding History

Paul Tudor Jones’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6M Buy
199,100
+170,900
+606% +$15.3M 0.03% 472
2026
Q1 		$2.03M Sell
28,200
-249,200
-90% -$19.2M ﹤0.01% 1848
2025
Q4 		$22M Buy
277,400
+46,600
+20% +$3.67M 0.04% 384
2025
Q3 		$17.4M Sell
230,800
-22,500
-9% -$1.54M 0.03% 497
2025
Q2 		$17.5M Buy
253,300
+19,500
+8% +$1.28M 0.04% 387
2025
Q1 		$15.8M Buy
233,800
+51,600
+28% +$3.09M 0.05% 281
2024
Q4 		$8.18M Buy
182,200
+54,100
+42% +$3.04M 0.03% 453
2024
Q3 		$8.05M Sell
128,100
-14,400
-10% -$840K 0.03% 500
2024
Q2 		$8.42M Buy
142,500
+93,300
+190% +$5.84M 0.04% 437
2024
Q1 		$3.92M Sell
49,200
-109,100
-69% -$8.33M 0.03% 720
2023
Q4 		$12.5M Buy
158,300
+8,200
+5% +$584K 0.1% 270
2023
Q3 		$10.5M Buy
150,100
+49,200
+49% +$3.49M 0.11% 223
2023
Q2 		$6.98M Buy
100,900
+73,700
+271% +$5.24M 0.08% 297
2023
Q1 		$2.02M Buy
+27,200
New +$2.28M 0.03% 784
2022
Q2 		– Sell
-5,600
Closed -$567K – 2182
2022
Q1 		$567K Buy
5,600
+3,600
+180% +$378K 0.01% 1196
2021
Q4 		$206K Buy
+2,000
New +$185K ﹤0.01% 2147
2016
Q2 		– Sell
-50,200
Closed -$5.21M – 1677
2016
Q1 		$5.21M Buy
+50,200
New +$4.88M 0.13% 114

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Paul Tudor Jones's CVS Position: Q2 2026 in Review

Paul Tudor Jones reduced its CVS Health (CVS) stake by 46% in Q2 2026, selling an estimated $27.8M and leaving 370,000 shares worth $38.3M. The position accounts for 0.05% of the portfolio, ranked #260.

Paul Tudor Jones first reported a position in CVS in Q2 2013 and has held it in 37 quarters since. The position peaked at $49M in Q1 2026. 2,059 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Paul Tudor Jones held 370,000 shares of CVS Health worth $38.3M as of Q2 2026.
  • Paul Tudor Jones sold 311,806 CVS Health shares in Q2 2026, an estimated $27.8M.
  • CVS Health made up 0.05% of Paul Tudor Jones's portfolio in Q2 2026, its #260 holding.
  • Paul Tudor Jones first reported a position in CVS Health in Q2 2013 and has held it in 37 quarters since.
  • Paul Tudor Jones's CVS Health position peaked at $49M in Q1 2026.
  • 2,059 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.